CRSP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - CRISPR Therapeutics AG

Watchlist Manager

Watchlist

Price: 52.61 USD 5.64% Market Closed

Market Cap: $5.1B

	CRISPR Therapeutics AG NASDAQ:CRSP	CH
	Siyata Mobile Inc NASDAQ:SYTA	CA
	Bolt Projects Holdings Inc NASDAQ:BSLK	US
	Pineapple Power Corporation PLC LSE:PNPL	UK
I	Indofood Sukses Makmur Tbk PT SWB:ISM	ID
	Semtech Corp NASDAQ:SMTC	US
	Nexstar Media Group Inc NASDAQ:NXST	US
A	Aruhi Corp TSE:7198	JP

Profitability Summary

CRISPR Therapeutics AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-15 754%

Negative 3Y Average Operating Margin

-3 162%

Declining Operating Margin

-560% > -15 754%

Negative Net Margin

-13 857%

Negative 3Y Average Net Margin

-2 980%

Declining Net Margin

-522% > -13 857%

Negative Free Cash Flow Margin

-10 387%

Negative 3Y Average Free Cash Flow Margin

-2 051%

Declining Free Cash Flow Margin

-375% > -10 387%

Negative ROE

-31%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-131%

Declining ROIC

-166% > -229%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.